The case for ‘successfully’ treating hormone naïve metastatic prostate cancer

It was one of those exciting first days of clinical rotation in medical school that remain vibrant when reminiscing our 'induction' into medicine. Our instructor presented a gentleman with a rare surgical complication and asked the group the incidence. We were extremely excited to unanimously agree 1% only to be reprimanded by the tone of his response: you obviously did your homework but keep in mind for this gentleman it is currently at 100%.